SRINIVAS AKKARAJU
CIK 1253170 · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$242.00M
Companies
22
Total Filings
191
Lifetime Open-Market Net
$171.88M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALMS | Director | 1,857,041 | $27.03 | $50.20M | $45.55M | 13 | 2026-07-02 |
| VTVT | Director | 106,000 | $31.08 | $3.29M | $0 | 8 | 2026-06-29 |
| SRRK | Director | 558,009 | $49.37 | $27.55M | $603.3K | 9 | 2026-06-08 |
| KLRS | Director | 19,408 | $3.34 | $64.8K | $5.90M | 3 | 2026-06-04 |
| MLYS | Director | 5,877,218 | $26.95 | $158.39M | $53.10M | 8 | 2026-02-20 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | Director | 11,444,503 | $9.81 | $112.27M | $0 | 1 | 2025-03-18 |
| Syros Pharmaceuticals, Inc. (SYRS) Delisted | Director | 1,795,760 | $0.00 | $718 | $7.14M | 22 | 2024-09-18 |
| CARGO Therapeutics, Inc. (CRGX) Delisted | 10%+ Owner | 4,415,689 | $4.47 | $19.74M | $14.99M | 1 | 2024-06-03 |
| CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Director | 0 | $40.39 | $0 | $27.49M | 8 | 2023-08-11 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 686,686 | $19.00 | $13.05M | $16.76M | 33 | 2023-05-25 |
| LENZ Therapeutics, Inc. (GRPH) Delisted | 10%+ Owner | 5,393 | $22.26 | $120.0K | $455.1K | 1 | 2021-12-20 |
| Jiya Acquisition Corp. (JYAC) Delisted | Director | 507,041 | $10.04 | $5.09M | $0 | 2 | 2021-08-30 |
| Seagen Inc. (SGEN) Delisted | Director | 2,183,433 | $228.74 | $499.44M | -$30.51M | 36 | 2020-05-19 |
| Aravive, Inc. (ARAV) Delisted | Director | 607,881 | $0.04 | $24.4K | $1000.0K | 4 | 2019-12-02 |
| Principia Biopharma Inc. (PRNB) Delisted | Director | 208,480 | — | — | $2.98M | 2 | 2019-01-10 |
| Aravive, Inc. (VSAR) Delisted | Director | 474,548 | — | — | $25.70M | 12 | 2018-10-16 |
| LIFE | Director | 133,295 | $18.80 | $2.51M | $4.48M | 5 | 2017-05-11 |
| SYNLOGIC, INC. (MIRN) Delisted | 10%+ Owner | 2,974,811 | — | — | $30.00M | 1 | 2015-10-06 |
| ZS Pharma, Inc. (ZSPH) Delisted | Director | — | — | — | $0 | 2 | 2015-06-29 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | Director | 1,340,283 | — | — | -$24.74M | 4 | 2012-06-28 |
| PHARMOS CORP (PARS) Delisted | Director | 14,226 | — | — | $0 | 4 | 2009-01-27 |
| BARRIER THERAPEUTICS INC (BTRX) Delisted | Director | 46,312 | — | — | -$9.01M | 2 | 2007-06-08 |
Recent Filings · Page 2 of 20
191 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-01 | ALMS | Buy (P) | +173,589 | $1.31M | EDGAR |
| 2025-11-24 | ALMS | Buy (P) | +125,743 | $905.3K | EDGAR |
| 2025-11-19 | ALMS | Buy (P) | +241,338 | $1.53M | EDGAR |
| 2025-11-17 | ALMS | Buy (P) | +276,179 | $1.45M | EDGAR |
| 2025-10-07 | SRRK | Buy (P) | +500,439 | $18.81M | EDGAR |
| 2025-09-25 | VTVT | Grant (A) | +106,000 | $1.62M | EDGAR |
| 2025-09-08 | MLYS | Buy (P) | +588,235 | $15.00M | EDGAR |
| 2025-09-05 | VTVT | Grant (A) | — | $0 | EDGAR |
| 2025-08-01 | ALMS | Grant (A) | — | $0 | EDGAR |
| 2025-06-12 | VTVT | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.